Prognostic Value Of Clinical Treatment Score Post-5 Years (Cts5) And Late Relapse Risk In Hormone Receptor-Positive Her2-Positive Breast Cancer In The North Central Cancer Treatment Group (Ncctg) N9831 (Alliance) And Nsabp B-31 (Nrg) Trials

CANCER RESEARCH(2021)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要